Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Other Non-Current Liabilities (2020 - 2025)

Maxcyte (MXCT) has disclosed Other Non-Current Liabilities for 6 consecutive years, with $263000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 4.01% to $263000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $263000.0 through Dec 2025, down 4.01% year-over-year, with the annual reading at $263000.0 for FY2025, 4.01% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $263000.0 at Maxcyte, up from $25000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $1.3 million in Q4 2022, with the low at $25000.0 in Q3 2025.
  • Average Other Non-Current Liabilities over 5 years is $581150.0, with a median of $351500.0 recorded in 2022.
  • The sharpest move saw Other Non-Current Liabilities surged 232.93% in 2023, then crashed 90.97% in 2025.
  • Over 5 years, Other Non-Current Liabilities stood at $450200.0 in 2021, then skyrocketed by 193.2% to $1.3 million in 2022, then plummeted by 78.56% to $283000.0 in 2023, then dropped by 3.18% to $274000.0 in 2024, then decreased by 4.01% to $263000.0 in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $263000.0, $25000.0, and $248000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.